SV Tech Ventures

SV Tech Ventures is a Palo Alto-based venture capital firm that specializes in early-stage investments in technology companies, focusing on both software and hardware innovations. The firm is composed of seasoned industry experts with extensive experience in entrepreneurship and investing across various fields. They collaborate closely with portfolio companies to provide support in business strategy, product development, fundraising, and talent acquisition. Additionally, SV Tech Ventures leverages a vast network of industry contacts to accelerate the growth of their investees. Since its inception, SV Tech Ventures has invested in over 80 high-tech companies through its funds I, II, and III. Notable exits include This is L (Organic Personal Care, acquired by Procter & Gamble), Original Stitch Inc (Custom Shirts, acquired by World Co.), NeuroVasc (Mechanical thrombectomy solution for brain revascularization, acquired), and Turning Point Therapeutics (Targeted Cancer therapies, publicly traded on Nasdaq). Other exits include Arrinex (Medical Device, acquired by Stryker), Neuvector (Full lifecycle container security platform), Oculli (High-resolution virtual AI software for image radar), and Apexgen (Clinical-stage biopharmaceutical company). SV Tech Ventures is committed to partnering with companies that develop advanced technologies with high barriers to entry and market leadership positions. They believe that such innovations, born from creativity, have the potential to make significant impacts on industries and society.

Advanced technology development, High barriers to entry, Significant market potential, Strong management team, Scalable business model, Innovative product or service, Clear path to profitability, Ability to achieve market leadership, Potential for significant industry impact, Alignment with SV Tech Ventures' investment strategy